2018. Efficacy Outcomes in the Phase 3 COMBI-AD Study of Adjuvant Dabrafenib Plus Trametinib vs Placebo in Patients with Stage III BRAFV600E/K-Mutant Melanoma. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S43. DOI:https://doi.org/10.25251/skin.2.supp.43.